Evidence map›Paper›PMID 39015425›Full record

ReviewBeilstein journal of nanotechnology2024

A review on the structural characterization of nanomaterials for nano-QSAR models.

Salvador Moncho, Eva Serrano-Candelas, Jesús Vicente de Julián-Ortiz, Rafael Gozalbes

Abstract readReview
In one paragraph

Review in Beilstein journal of nanotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Nanoinformatics: spanning scales, systems and solutions.Beilstein journal of nanotechnology · 2026
    Article
  3. Review
  4. Review
  5. Informatics-Based Design of Virtual Libraries of Polymer Nano-Composites.International journal of molecular sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Salvador MonchoProtoQSAR S.L., CEEI Valencia, Avda. Benjamin Franklin 12, 46980 Paterna, Spain.ORCID https://orcid.org/0000-0003-1631-5587
Eva Serrano-CandelasProtoQSAR S.L., CEEI Valencia, Avda. Benjamin Franklin 12, 46980 Paterna, Spain.ORCID https://orcid.org/0000-0002-8929-5364
Jesús Vicente de Julián-OrtizUniversitat de València, Facultad de Farmacia, Departamento de Química Física, Unidad de Investigación de Diseño de Fármacos y Conectividad Molecular, Avda. Vicent Andrés Estellés 0, 46100 Burjassot, Spain.ORCID https://orcid.org/0000-0001-9403-8744
Rafael GozalbesProtoQSAR S.L., CEEI Valencia, Avda. Benjamin Franklin 12, 46980 Paterna, Spain.ORCID https://orcid.org/0000-0003-2111-7964

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Quantitative structure-activity relationship (QSAR) models are routinely used to predict the properties and biological activity of chemicals to direct synthetic advances, perform massive screenings, and even to register new substances according to international regulations. Currently, nanoscale QSAR (nano-QSAR) models, adapting this methodology to predict the intrinsic features of nanomaterials (NMs) and quantitatively assess their risks, are blooming. One of the challenges is the characterization of the NMs. This cannot be done with a simple SMILES representation, as for organic molecules, because their chemical structure is complex, including several layers and many inorganic materials, and their size and geometry are key features. In this review, we survey the literature for existing predictive models for NMs and discuss the variety of calculated and experimental features used to define and describe NMs. In the light of this research, we propose a classification of the descriptors including those that directly describe a component of the nanoform (core, surface, or structure) and also experimental features (related to the nanomaterial's behavior, preparation, or test conditions) that indirectly reflect its structure.

Indexed as

descriptorsnanomaterialsnano-QSARQSARtoxicity

Identifiers

PMID39015425
PMCPMC11250003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.